{"companyId":285725,"requestedLanguage":"en","resolvedLanguage":"en","availableLanguages":["en","en-US","ja"],"companyName":"Zai Lab Limited","headOfficeLocation":"Building B, 899 Halei Road Pudong, 201203 China","presidentName":"Ying Du","companySummary":null,"stockCode":"ZLAB","currency":"USD","capital":null,"sales":null,"employees":1784,"employeesConsolidated":null,"humanCheck":false,"domains":["zailaboratory.com"],"businessContents":["development and commercialization of omadacycline in the greater China region","develop innovative therapeutics in China for both local and global patients","biologics drug discovery","Biotherapeutics Clinical Production","drug discovery","drug development","manufacturing","commercialization"],"relations":[{"detailNumber":1,"relationCompanyName":"GE Healthcare","relationCompanyId":16478,"url":null,"linkUrl":null,"remarks":null,"lastCheckDate":"2026-10-11","raGroup":0,"raParent":0,"raChild":0,"raCustomer":0,"raSupplier":0,"raPartnership":50,"raFinance":0,"raInvest":0},{"detailNumber":2,"relationCompanyName":"MediLink Therapeutics","relationCompanyId":null,"url":null,"linkUrl":null,"remarks":"関連会社未登録","lastCheckDate":"2026-10-11","raGroup":0,"raParent":0,"raChild":0,"raCustomer":0,"raSupplier":0,"raPartnership":50,"raFinance":0,"raInvest":0},{"detailNumber":3,"relationCompanyName":"innovaTV","relationCompanyId":null,"url":null,"linkUrl":null,"remarks":"関連会社未登録","lastCheckDate":"2026-10-11","raGroup":0,"raParent":0,"raChild":0,"raCustomer":0,"raSupplier":0,"raPartnership":50,"raFinance":0,"raInvest":0}],"dataSources":[{"detailNumber":2,"url":"https://www.zailaboratory.com/paratek-pharmaceuticals-broadens-clinical-profile-of-nuzyra-omadacycline-with-new-eccmid-2019-data-presentations/","scoreAbout":43,"scoreBusiness":0,"scoreGroup":0,"scoreCustomer":0},{"detailNumber":3,"url":"https://www.zailaboratory.com/publications/wang-b-et-al-zl-1201-a-differentiated-cd47-therapeutic-antibody-with-a-potentially-improved-hematological-safety-profile-presented-as-a-poster-presentation-at-the-aacr-virtual-2021-congress-held/","scoreAbout":40,"scoreBusiness":0,"scoreGroup":0,"scoreCustomer":0},{"detailNumber":4,"url":"https://www.zailaboratory.com/ge-healthcare-zai-lab-enter-a-strategic-partnership-to-co-develop-a-world-class-biotherapeutics-clinical-production-center/","scoreAbout":0,"scoreBusiness":24,"scoreGroup":0,"scoreCustomer":19},{"detailNumber":5,"url":"https://www.zailaboratory.com/zai-lab-announces-strategic-partnership-and-global-license-agreement-with-medilink-therapeutics-for-a-next-generation-antibody-drug-conjugate-program-in-oncology/","scoreAbout":0,"scoreBusiness":0,"scoreGroup":0,"scoreCustomer":18},{"detailNumber":6,"url":"https://www.zailaboratory.com/zai-lab-reports-full-year-2017-financial-results-and-corporate-update/","scoreAbout":10,"scoreBusiness":0,"scoreGroup":0,"scoreCustomer":0},{"detailNumber":7,"url":"https://www.zailaboratory.com/zai-lab-announces-financial-results-and-corporate-progress-for-the-six-months-ended-june-30-2018/","scoreAbout":10,"scoreBusiness":0,"scoreGroup":0,"scoreCustomer":0}]}